chrisvoncsefalvay/vaers-outcomes huggingface dataset:
04Aug admitted to the hospital for Portal Vein Thrombosis; (PVT) - Blood clot in left portal vein of my liver.; On 01Aug started having abdominal pain; 22Jul started feeling sick with sore throat; 22Jul started feeling sick with sore throat; flu like symptoms; This is a spontaneous report from a contactable consumer (patient). A 38-year-old Non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0181), via an unspecified route of administration, administered in Arm Right on 15Jul2021 (at age of 38 years old) as single dose for COVID-19 immunisation. Medical history included Crohn's disease, Known allergies: Shrimp. There were no concomitant medications. No other vaccine in four weeks. No Other medications in two weeks. No COVID prior vaccination. No COVID tested post vaccination. 15Jul2021 date of 1st dose, 22Jul2021 started feeling sick with sore throat, flu like symptoms. On 01Aug2021 started having abdominal pain, waited until the pain was unbearable and went to ER on 04Aug. 04Aug admitted to the hospital for Portal Vein Thrombosis (PVT)-Blood clot in left portal vein of liver. AE resulted in: Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). No. days hospitalization: 4. AE treatment (Xarelto - Blood thinner). The outcome of the events feeling sick with sore throat, flu like symptoms was recovered in 2021, for other events was recovered on Aug2021.
On 4/7/21, 17 days after I received the second Moderna shot I experienced after effects similar to what I had the day after the second shot on 3/22/21. Both events lasted two days. Fever, brain fog and weakness.
Face swelling; Chills; 99.0 degree fever; A spontaneous report was received from a consumer, concerning his mother, a 91-year- old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced chills, 99.0-degree fever and face swelling.  The patient medical history included high blood pressure. The concomitant medications reported included lisinopril, metoprolol 50 mg and diltiazem hydrochloride for high blood pressure.  On 15-Jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 013620A) via unknown route for prophylaxis of COVID-19 infection.  On 15-Jan-2021, after the vaccination, the patient experienced events chills and a 99.0-degree fever that night and the next day on 16-Jan-2021, the patient experienced face swelling. Treatment for the events included loratadine.  Action taken with mRNA-1273 in response to the events were not provided.  The outcome of the events chills, pyrexia and swelling of face was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
12-15 hours after injection no fever, chills, signif, swelling, swelling on (L) lat neck, upper (L) chest and breast, pain in bones and headache. Tested severely for 48 hours and now 5 d after 50% better.
pt had fever up to 103 x 24hr p/vax; given APAP q4hr x 24;24hr p/vax temp up to 105.8;called family MD & clinic advised to go to ER;mom denies other sx;430Pm checked & mom seen @ ER given advil & ATB & temp dec;pt fine @ this time;
Information has been received from a mother she told the school nurse concerning her child who on an unspecified date was vaccinated with the dose of VARIVAX (Merck) (LOT# not reported). The mother was noted that the child developed chicken pox, in spite of being immunized with VARIVAX (Merck). No further information is available at this time of reporting. This is the third of three reports concerning the siblings. No further information is available.
About 30 minutes after my vaccination, while on my way home, the left side of my face went numb. The left side felt numb and I kept checking my face for signs of a stroke. My numbness lasted 5 days as well as the feeling that the left side of my face was bigger than the other. Currently, my left arm and hand feel numb which just began today (12/5). My PCP referred me to a neurologist for evaluation.
Patient was nervous, passed seconds after receiving vaccine, hit chin on table, 911 was called to make sure patient was ok, vitals were ok when EMT checked patient out, parents refused to send patient to hospital. No further treatment needed. Follow up call was made for patient in the evening and father said patient was feeling great.
Information has been received from a registered nurse concerning her 4 year old son who in October 2005, was vaccinated with MMR II. One month after receiving the vaccine the patient had lost the ability to "snap" his fingers. Prior to the vaccination, the patient was able to "snap" his fingers but after the vaccination he could not anymore. The patient had sought unspecified medical attention. The patient's losing the ability to "snap" his fingers persisted. Additional information has been requested.
pt recv vax; w/in 2 hrs, raised red welt; screamed for about 6 hrs; fell asleep for about 2 min; w/in 2 days, was having blank stare sz and myoclonics; PAR did not recognize them as sz;adm to hosp for gen sz;on meds;
9/1/2008 fever, vomiting and diarrhea; 9/3/2008 had 3 seizures, requiring hospitalization. CT, MRI, EEG all normal. Treated with ativan and phenobarbital initially, now on maintanence phenobarbital.  12/18/08 Reviewed hospital medical records of 9/03-9/07/2008. FINAL DX: new onset seizures Records reveal patient experienced witnessed generalized seizures lasting 1-2 min x 3 on day of admission.  Had concurrent fever, vomiting & diarrhea.  Loaded w/antiseizure meds.  No further seizures in hospital.  D/C to home on continued meds & w/neuro f/u.
Feeling freezing cold; Dizzy; Body ache; Weakness; Feeling sicker than a dog; flu like symptoms; Headache; Muscle pain; Joint pain; Fatigue; A spontaneous report was received from a 63 year old female consumer who was participating in the mRNA-1273 Emergency Use Program and experienced feeling freezing cold, muscle pain, joint pain, dizzy, body aches, headache, feeling sicker than a dog, having every flu symptom except fever, weakness and fatigue.    The patient's medical history was not provided. No relevant concomitant medications were reported.   On 03 Jan 2021, approximately 15 hours before the events, the patient received their first of two planned doses of mRNA-1273 (Lot 011-20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 4 Jan 2021, the patient reported she experienced feeling freezing cold, muscle pain, joint pain, dizzy, body aches, headache, feeling sicker than a dog, having every flu symptom except fever, weakness and fatigue.   No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of feeling freezing cold, muscle pain, joint pain, dizzy, body aches, headache, feeling sicker than a dog, having every flu symptom except fever, were resolved on 5 Jan 2021. The outcome of weakness and fatigue, were considered not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
5-11 2 min seizure like activity. 5-12 2 further episodes (approx 2 mins each) of siezure like activity. Approx 5-18 left leg swollen entirely.
Severe arm/shoulder pain within a few hours. By the next day, I could not raise my arm at all and could not work the day after that (i only use a computer for work and could not raise my arm high enough to type). Severe pain dissipated over a week but chronic daily pain in shoulder continued. I could not sleep on left side and some activities became difficult.
About 30 minutes after I got my first Pfizer Covid vaccine shot I got a headache and started feeling sick. My headache continued to get worse throughout the day so I went to bed around 6pm to try to sleep it off. When I woke up the next morning I still had a headache but it continued to get worse. I also noticed that the vision in my right eye was extremely blurry. I was barely able to drive myself to work because the head pain became a sharp eye pain and my vision continued to get worse. As soon as I got to work I had my co-worker drive me to an eye doctor. At the eye doctor, I had 2 technicians and 2 doctors read my IOP eye pressure at 74. They had never seen pressure so high so they got me in with an eye specialist immediately. I had to be driven to the eye specialist for an emergency visit, where the doctor examined my eye and said it looked like the inflammation in my eye happened very recently and quickly and he had never seen a case like mine. He had to puncture my eyeball to relieve the pressure and fluid gushed down my face. The doctor said if he hadn?t relieved the pressure, my eye would have burst later that day and the eye would have detached at the optic nerve, which would lead to immediate blindness. I was sent to do extensive testing with a rheumatologist to see if I had any underlying health conditions and every test came out normal. I was put on meds to regulate my eye pressure and eye inflammation and after a couple weeks, I was able to wean off the medication. When I was almost weaned off the medication, I got the second dose of the Pfizer vaccine. After the second vaccine dose, I happened to have an eye appointment a few days later and the doctor discovered my left eye had high pressure and was now swelling and inflamed. So then I had to start using medication in my left eye to reduce the swelling. Then I saw a doctor to do a full work up on me, he looked at all my medical testing data and he said my eye reactions were definitely caused by the vaccine. I am still seeking medical consultation so I don?t go blind.
Welts; It's very itchy; Rash all over his body/started on his arms/Then it was on his stomach; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Welts), RASH PRURITIC (It's very itchy) and RASH (Rash all over his body/started on his arms/Then it was on his stomach) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (Welts), RASH PRURITIC (It's very itchy) and RASH (Rash all over his body/started on his arms/Then it was on his stomach). At the time of the report, URTICARIA (Welts), RASH PRURITIC (It's very itchy) and RASH (Rash all over his body/started on his arms/Then it was on his stomach) outcome was unknown. Concomitant product use was not provider by the reporter.Treatment information was not provided.
Patients came back today (9/22) 3 days after her shot complaining about a rash on her arm - she has not received any treatment.
Pt was given the SHINGRIX vaccine Subcutaneously 9/21/2018 when it should have been given Intramuscularly. Over the course of a few days, they reported redness and swelling at the incorrect injection site. She did not seek medical treatment as they did not deem in necessary. Symptoms have resolved by 09/26/2018.
The patient reported that she was light headed immediately after receiving the vaccine. That evening and night, the patient said she felt her heart was pounding and reported that her blood pressure was elevated above 200. She noted the symptoms were present throughout the night and did not resolve until the morning the day after the vaccine. She had contacted her office that day and they advised that she should go to the ER/urgent care, but she declined.
About 3am woke up with chills; headache; Arm was very sore.; Saturday, was very tired/lethargic/Felt blah all day, tired; out of breath; This 57- year-old female patient contactable consumer (reported for herself) received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on Jan2021 at 12:00 PM (at the age of 57-years-old) as a single dose for COVID-19 immunization, in right arm. The facility where COVID-19 vaccine was administered was at a Workplace clinic. She has had no other vaccines on the same day or in the past 4 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Medical history included: allergy to pumpkin. Concomitant medication included: Osphena 60mg; VitD 2000IU; Vit C 1000mg; Zinc 50mg. Patient received dose 1 of Pfizer vaccine on a Friday at 12 noon. Felt fine all day. About 3am woke up with chills and a headache. Arm was very sore. Saturday, was very tired/lethargic all day. Slept 10 hrs, awoke with a headache (but no chills) and had breakfast, fell back asleep another 2 hrs, then another 2-hr nap early evening. Felt blah all day, tired and out of breath. Went to bed much earlier than normal. Felt good Sunday but arm still sore. It's Monday at 4pm and arm is still very sore to the touch. The clinical outcome of the events chills, headache, arm very sore, very tired/lethargic, out of breath were recovering. It was reported that since the vaccination, the patient had not been tested for COVID-19.  Information on the lot/batch number has been requested.
Information has been received from a registered pharmacist concerning a 74 year old male patient with no drug reactions/allergies, who on 04-FEB-2009 was vaccinated subcutaneously in the left arm with a 0.65 mL dose of ZOSTER vaccine live (Oka/Merck) (Lot # 662998/1620X).  There was no concomitant medication.  On 05-FEB-2009 the patient developed a rash on his right arm, chest and back after receiving ZOSTER vaccine live (Oka/Merck).  The patient was seen at an office.  There were no laboratory or diagnostic tests performed.  The patient was treated with PREDNISONE (unspecified) and the rash resolved.  On an unspecified date, the patient recovered.  Additional information has been requested.
got the vaccination and still got shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got the Shingles vaccine and still got the shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Information has been received from an other health professional concerning a 26 year old female in sales with no pre-existing allergies, birth defects or medical conditions reported.  On 21-AUG-2006, in the pm, the patient was vaccinated in the left deltoid with the first dose of HPV rLi 6 11 16 18 VLP vaccine (yeast) (lot#653650/0702F). Concomitant therapy included ethinyl estradiol/norgestimate (ORTHO TRI CYCLEN).  There were no illness noted at the time of vaccination.  On 21-AUG-2006, in the pm, the patient experienced an unspecified adverse event.  The patient went to the emergency room and it was reported that she "went home that day".  On 21-AUG-2006, the patient underwent a complete blood count (CBC), comprehensive metabolic panel, estimated glomerular filtration rate (GFR), urine microscopic analysis, urinalysis and an electrocardiogram (EKG).  On 21-AUG-2006, the patient's laboratory data revealed an absolute neutrophil count noted as 7.9 K/ul, urine ketones noted as >-80, a urine white blood cell count noted as 30-40/hpf and urine bacteria noted as 4+.  On 21-AUG-2006, the patient recovered from the events.  Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 77-year-old female patient who received SHINGRIX for prophylaxis. On 21st August 2018, the patient received SHINGRIX. On 21st August 2018, several hours after receiving SHINGRIX, the patient experienced injection site pain. On 22nd August 2018, the patient experienced sweating. On an unknown date, the outcome of the injection site pain and sweating were not recovered/not resolved. It was unknown if the reporter considered the injection site pain and sweating to be related to SHINGRIX. Additional details were provided as follows: The patient's husband reported that the patient received SHINGRIX vaccine in left arm at mid morning on the day before reporting (yesterday), and she was sore at the injection site late yesterday and tender. On the date of reporting, the patient was more tender at the site, after rising this morning his wife was experiencing perspiration and she was soaking wet. The patient had denied permission to contact their physician.
Patient received vaccine at 0845 and left after the specified 15 minute waiting period. At 0940, the patient returned to the vaccine clinic stating that he was short of breath and his throat felt tighter than before. Arm examined and no hives or redness present, patient denied itching and hives. Patient denied that throat tightness was getting worse. PharmD and RN present and took vital signs and called house manager. Verified NKDA and then administered 25mg of PO diphenhydramine. Pt then transported via wheelchair for further workup.
Urinary tract infection; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Urinary tract infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced URINARY TRACT INFECTION (Urinary tract infection). At the time of the report, URINARY TRACT INFECTION (Urinary tract infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.  The patient was prone to UTI's.
cold symptoms; This is a spontaneous report from a contactable consumer patient. This 55-year old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3248) shot at single dose on 11Jan2021 via an unknown route at left arm Covid-19 vaccination. Medical history and concomitant drug were reported as "none".  Patient stated that she got a shot yesterday (11Jan2021) and had cold symptoms today (12Jan2021), and further stated that the cold symptoms come and go.  No investigation assessment performed. No treatment performed.  Outcome of the event was resolving.
An 18 month old patient up to date on her Hep B vaccine but due for both DTaP and IPV was incorrectly given KINRIX. Provider asked nurse what combination vaccines were available and nurse replied KINRIX. Provider did not check box to confirm appropriate age range and ordered KINRIX. Nurse administered KINRIX. Patient should have either gotten PEDIARIX (and an extra dose of Hep B) or 2 separate vaccines. After the error was realized our pharmacist called the company that manufactures KINRIX and confirmed that KINRIX can be counted as appropriate dose of both vaccines for the child and the vaccine schedule can proceed as prior. The child had no adverse reaction. Parents have been notified.
Purple armpit and under arm. Flu like symptoms. Headache chills body aches.
My COVID-19 Infection symptoms started on 01/11/2023 at 09:30pm. I was congested before going to bed. On the next day 01/12/2023 I had a severe cough, mucus, phlegm, and headaches. I did a home COVID-19 test in the morning which was positive. After testing positive I called my doctor right away. I spoke with a nurse and  she prescribe me with Paxlovid for 5 days. I took it till 01/16/2023. I also took over the counter  Robitussin for cough and Tylenol as per needed. I took a COVID-19 home test again on 01/18/2023  which was negative. I still have the lingering cough as of today 01/20/2023. On 12/16/2023 I received an IV infusion   recommended by my Oncologist since I was immune compromised.
scratchy throat; itchy eyes; drainage from eyes; chills; slight fever; felt like she had a severe head cold; had been hit by a truck; Initial information received on 18-Nov-2019 regarding an unsolicited valid non-serious case received from a consumer/non-HCP.  This case involves a 73 years old female patient who experienced throat (throat irritation), itchy eyes (eye pruritus), drainage from eyes (eye discharge), felt like she had a severe head cold (nasopharyngitis), chills (chills), slight fever (pyrexia) and feeling like she "had been hit by a truck " (unevaluable event), while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  Medical history, medical treatment, vaccination and family history were not provided.  On 12-Nov-2019, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot number not reported via unknown route in the left deltoid.  On 12-Nov-2019, the patient developed a non-serious head cold (nasopharyngitis) and feeling like she "had been hit by a truck " (unevaluable event) 6 hours following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  On an unknown date patient developed a non-serious scratchy throat (throat irritation), itchy eyes (eye pruritus), drainage from eyes (eye discharge), chills (chills), slight fever (pyrexia) 36 hours following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE  Other relevant tests were not reported.  Final diagnosis was slight fever, chills, throat irritation, eye pruritus, eye discharge, nasopharyngitis and unevaluable event.  The patient was treated with ibuprofen (ADVIL).  The event outcome was reported as recovered for all the events.  Information on the batch number was requested.
fatigue 1/21, nausea  on 1/22, body aches, sweating/hot flashes, headache 1/21
Newborn boy received Hep-B vaccine at 15:20 on 8/1/01. Fifteen minutes later, the RN noticed the baby was cyanotic and not breathing. The baby was stimulated and O2 via face mask was given and baby turned pink. Baby was transferred to NICU and discharged on 8/2/01.
This spontaneous report was received from a licensed practical nurse (L.P.N.) and refers to multiple unspecified patient of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapy were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of ROTATEQ, orally, lot number: M035455, expiry date: 22-APR-2018. Temperature time excursion was 1 hour >46 degree of Fahrenheit but< 77 degree of Fahrenheit , and 3 hours between 32 degree of Fahrenheit  and 36 degree of Fahrenheit. There was no previous temperature excursion. Data logger was involved. No adverse event was reported. This is one of several reports from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1702USA007041: US-009507513-1702USA006595: US-009507513-1702USA007040: